SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 146 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2017. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $241,000 | -39.1% | 83,000 | -6.7% | 0.29% | -36.1% |
| Q2 2017 | $396,000 | -4.6% | 89,000 | 0.0% | 0.46% | +1.3% |
| Q1 2017 | $415,000 | -23.4% | 89,000 | 0.0% | 0.45% | -21.5% |
| Q4 2016 | $542,000 | +14.6% | 89,000 | 0.0% | 0.58% | +29.0% |
| Q3 2016 | $473,000 | +39.9% | 89,000 | 0.0% | 0.45% | +41.3% |
| Q2 2016 | $338,000 | +37.4% | 89,000 | 0.0% | 0.32% | +40.9% |
| Q1 2016 | $246,000 | -32.2% | 89,000 | +39.1% | 0.22% | -20.8% |
| Q4 2015 | $363,000 | +7.1% | 64,000 | 0.0% | 0.28% | +4.4% |
| Q3 2015 | $339,000 | -38.9% | 64,000 | -4.3% | 0.27% | -28.0% |
| Q2 2015 | $555,000 | +79.6% | 66,900 | 0.0% | 0.38% | +64.3% |
| Q1 2015 | $309,000 | +103.3% | 66,900 | +33.8% | 0.23% | +180.5% |
| Q4 2014 | $152,000 | – | 50,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |